Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulant Prophylaxis/Therapy”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Post-approval studies (Phase 4)Study completedNCT01127984
What this trial is testing

Pocket Haematoma Prevention in Patients Who Required Implantation/Replacement of a Pacemaker or Implantable Cardiac Defibrillator. The PHP Study.

Who this might be right for
Pacemaker ImplantationPocket Hematoma and BleedingAntiplatelet Therapy or Oral Anticoagulants
Careggi Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00320255
What this trial is testing

Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Who this might be right for
ThrombosisCancerPulmonary Embolism
Bristol-Myers Squibb 130
Testing effectiveness (Phase 2)Study completedNCT00994292
What this trial is testing

Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes

Who this might be right for
Acute Coronary Syndrome
Astellas Pharma Europe B.V. 1,276
Large-scale testing (Phase 3)Study completedNCT05185804
What this trial is testing

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

Who this might be right for
COVID-19Venous Thromboembolism
PharmaDiall Ltd. 399
Post-approval studies (Phase 4)Study completedNCT03284827
What this trial is testing

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement

Who this might be right for
Aortic Valve Stenosis
Duk-Woo Park, MD 235
Large-scale testing (Phase 3)Study completedNCT00262600
What this trial is testing

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Who this might be right for
Atrial FibrillationStroke
Boehringer Ingelheim 18,113
Not applicableStudy completedNCT02468102
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Who this might be right for
Acute Coronary SyndromeVenous ThrombosisPulmonary Embolism+1 more
Bayer 99,999
Not applicableLooking for participantsNCT07458191
What this trial is testing

Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
Bosnalijek D.D 800
Not applicableLooking for participantsNCT05900414
What this trial is testing

RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University of Calgary 60
Not applicableUnknownNCT04419012
What this trial is testing

Polish Atrial Fibrillation (POL-AF) Registry

Who this might be right for
Atrial Fibrillation
Jan Kochanowski University 4,000
Large-scale testing (Phase 3)Looking for participantsNCT07012629
What this trial is testing

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Who this might be right for
Covert Brain Infarction
Aarhus University Hospital 1,652
Testing effectiveness (Phase 2)Ended earlyNCT04106700
What this trial is testing

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Who this might be right for
Venous Thromboembolism
Instituto de Investigacion Sanitaria La Fe 60
Not applicableStudy completedNCT01947998
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 50,299
Testing effectiveness (Phase 2)UnknownNCT05189002
What this trial is testing

Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement

Who this might be right for
Venous Thromboembolism
PharmaDiall Ltd. 240
Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Not applicableUnknownNCT01101256
What this trial is testing

Determination of Residual Anticoagulatory Effects of Fondaparinux

Who this might be right for
Anticoagulant Prophylaxis/Therapy
Johann Wolfgang Goethe University Hospital 110
Large-scale testing (Phase 3)Ended earlyNCT00243178
What this trial is testing

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

Who this might be right for
Atrial FibrillationVascular Risk
Sanofi 6,706
Large-scale testing (Phase 3)Not Yet RecruitingNCT07454707
What this trial is testing

Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

Who this might be right for
Stroke, Ischemic
Sunnybrook Health Sciences Centre 1,204
Testing effectiveness (Phase 2)Study completedNCT00684307
What this trial is testing

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
AstraZeneca 1,084
Large-scale testing (Phase 3)Study completedNCT02801669
What this trial is testing

Study of DU-176b Aged 80 Years or Older

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Co., Ltd. 984
Load More Results